Imagine you’re trying to get a prescription for a medicine that helps you lose weight, a “weight-loss jab.” Sounds simple enough, right? But what if the online pharmacy you’re using isn’t doing its due diligence, potentially putting your health at risk? That’s the unsettling picture painted by a recent investigation from Which?, a consumer rights watchdog. They found that several well-known online pharmacies – Superdrug, MedExpress, Voy, and ZAVA – were dispensing these powerful weight-loss medications without properly checking patient information, even when clear red flags were raised. It’s like a gatekeeper letting people into a restricted area without asking for their ID, and in this case, the restricted area is your health.
Which? decided to put these pharmacies to the test. They sent an undercover reporter who deliberately provided false information: a fake GP address and a fabricated claim of high blood pressure. The reporter even admitted to having a “genuine overweight BMI,” which, on its own, might make them seem like a suitable candidate for the jabs. Yet, despite these inconsistencies and the lack of proper verification, all four pharmacies sold the weight-loss medication. This is a big deal because the General Pharmaceutical Council (GPhC) has clear rules. They insist that prescribers – the doctors or pharmacists who write your prescription – must independently verify your information. This means they should have a real, timely two-way conversation with you, or check your official medical records, or even contact your own GP. The fact that these pharmacies seemingly bypassed these crucial checks is concerning, to say the least.
When confronted, the pharmacies offered various explanations, some more reassuring than others. Superdrug, for instance, stated that their doctors used their “clinical judgement” based on the information provided by the patient. They also claimed to follow guidelines from NICE and the GPhC. However, the Which? investigation suggests that this “clinical judgement” might not have been as thorough as it should have been. Voy had a more nuanced defense, arguing that while they adhere to GPhC guidance on independent verification, it “does not require every individual data point to be independently verified in all cases.” They focus on verifying crucial details like weight, height, or BMI, often through video calls or live photos. They also mentioned that their clinicians assess information and decide if further verification is needed, and they always seek patient consent to inform their GP. If consent isn isn’t given, clinicians make a “risk-based decision.” While this sounds like a more robust approach, the fact that their system allowed the undercover reporter to get a prescription with false information raises questions about its effectiveness.
ZAVA expressed regret and stated that they rely on the “integrity and honesty of our patients.” They even pointed out that their terms and conditions classify providing false information as a criminal offense. They emphasized that their doctors review each case individually and that their processes have passed GPhC inspections. They also highlighted a point in the guidance that allows treatment even if GP information isn’t available or if a patient doesn’t consent to their GP being contacted, relying on the doctor’s professional judgment. This line of reasoning, while legally permissible in some contexts, still brings us back to the initial problem: how effectively are these online platforms assessing honesty and managing risk when crucial patient data is unverified? MedExpress, the fourth pharmacy, chose not to comment at all, which, in itself, speaks volumes.
The heart of this issue lies in the balance between convenient access to medication and patient safety. Online pharmacies offer a level of discretion and ease that many people appreciate, especially for sensitive health concerns like weight management. However, this convenience cannot come at the expense of proper medical oversight. Weight-loss jabs are not without their risks and side effects, and they are only recommended for specific individuals with a BMI of 30 or higher, or obese adults with weight-related health problems. If a patient can easily obtain these medications by providing false information, without their true medical history being checked, they could be putting themselves at serious risk. It also undermines the guidance designed to ensure these powerful drugs are used responsibly and effectively.
Ultimately, this investigation serves as a critical reminder for both online healthcare providers and patients. For providers, it’s a call to re-evaluate their verification processes and ensure they are truly robust enough to protect patients. “Clinical judgement” and reliance on patient honesty, while important, cannot be the sole pillars of safe prescribing, especially when regulatory bodies demand independent verification. For patients, it’s a stark warning about the potential dangers of seeking medical treatment without complete transparency and proper medical checks. The ease of online access should never overshadow the importance of thorough medical assessment. Our health isn’t something to take shortcuts with, and online pharmacies have a fundamental responsibility to ensure they are being guardians of our well-being, not just dispensers of prescriptions.

